Savyon, Israel

Roy Noy

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 22(Granted Patents)


Location History:

  • Ganei Yehuda, IL (2011)
  • Savyon, IL (2013)

Company Filing History:


Years Active: 2011-2013

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Roy Noy: Innovator in Cancer Treatment

Introduction

Roy Noy is a notable inventor based in Savyon, Israel, recognized for his contributions to cancer treatment methodologies. With a total of two patents, Noy has made significant strides in the field of medical innovation, particularly in the area of adoptive cell transfer therapy.

Latest Patents

Noy's latest patents include a method of predicting responsiveness to autologous adoptive cell transfer therapy. This method involves analyzing the frequency of tumor infiltrating lymphocytes (TILs) with a specific CD8CD28CD152 signature in a subject's sample. A higher frequency of these TILs indicates a positive response to cancer treatment. Additionally, he has developed fusion proteins that consist of consecutive amino acids from various components, including a cytomegalovirus human MHC-restricted peptide and a variable region from an antibody's heavy and light chains. These innovations provide new avenues for cancer treatment and diagnostics.

Career Highlights

Throughout his career, Roy Noy has worked with prominent organizations such as the Technion Research & Development Foundation Limited and Teva Pharmaceutical Industries Limited. His work in these institutions has allowed him to advance his research and contribute to significant medical breakthroughs.

Collaborations

Noy has collaborated with esteemed colleagues, including Yoram Reiter and Kfir Oved. These partnerships have fostered a collaborative environment that enhances the

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…